<SEC-DOCUMENT>0001564590-18-015483-index.html : 20180612 <SEC-HEADER>0001564590-18-015483.hdr.sgml : 20180612 <ACCEPTANCE-DATETIME>20180612165509 ACCESSION NUMBER: 0001564590-18-015483 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20180612 DATE AS OF CHANGE: 20180612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-224840 FILM NUMBER: 18895044 BUSINESS ADDRESS: STREET 1: 520 PIKE STREET STREET 2: SUITE 2250 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 520 PIKE STREET STREET 2: SUITE 2250 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20080821 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 </SEC-HEADER> <DOCUMENT> <TYPE>S-1/A <SEQUENCE>1 <FILENAME>achv-S-1A.htm <DESCRIPTION>FORM S-1/A <TEXT> Document 1 - file: achv-S-1A.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1 <SEQUENCE>2 <FILENAME>achv-ex11_127.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: achv-ex11_127.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3 <SEQUENCE>3 <FILENAME>achv-ex39_128.htm <DESCRIPTION>EX-3.9 <TEXT> Document 3 - file: achv-ex39_128.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4 <SEQUENCE>4 <FILENAME>achv-ex47_129.htm <DESCRIPTION>EX-4.7 <TEXT> Document 4 - file: achv-ex47_129.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5 <SEQUENCE>5 <FILENAME>achv-ex51_49.htm <DESCRIPTION>EX-5.1 <TEXT> Document 5 - file: achv-ex51_49.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g201806121934441384125.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g201806121934441384125.jpg
</DOCUMENT> </SEC-DOCUMENT>